
Keywords: FVII، عامل VII; Hemophilia A; Hemophilia B; Inhibitors; NovoSeven®; rVIIa-FP; PROLONG-7FPFEIBA®, Factor Eight Bypassing Activity; FIX, factor IX; FVII, factor VII; FVII:Ag, factor VII antigen; FVIIa, activated factor VII; FVIII, factor VIII; INR, international normalized